Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib was more effective than a placebo in regrowing hair in adults with alopecia areata after 36 weeks.

Oral JAK inhibitors effectively treat alopecia areata and are generally well-tolerated.

5ARIs effectively treat and manage BPH by reducing prostate size and symptoms.

The steroids allopregnanolone and allotetrahydrodeoxycorticosteron worsened absence seizures in rats.

Pentoxifylline is a safe and effective alternative to triamcinolone acetonide for treating localized alopecia areata.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

New progesterone-based compounds can block male hormones.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

New medications could improve treatment for severe alopecia areata in Australia.

TPA promotes hair growth by increasing stem cell activity and activating specific cell signals.

Using anthralin and calcipotriene together might help treat tough cases of alopecia areata, but more research is needed to understand how it works.

Longer TA repeats in the SRD5A2 gene may increase acne risk in Chinese people.

Neurosteroids change how GABA_A receptors work in the brain, which could be important for treating temporal lobe epilepsy.

New testosterone analogs show promise for male contraception with better activity and potentially fewer side effects.

Neurosteroids may help treat disorders with too much dopamine activity.

These drugs cause hair growth without affecting testosterone or adrenal hormones.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Steroid sulfatase inhibitors could help treat hormone-related disorders and cancers.

The research identified genes and non-coding RNAs in cells that could be affected by testosterone, which may help understand hair loss and prostate cancer.

JAK inhibitors like tofacitinib are effective and safer for severe alopecia areata than glucocorticosteroids.

Targeting the AhR pathway may help treat alopecia areata.

Understanding how androgens and their receptors work can lead to improved treatments for skin diseases.

Testosterone causes hair loss in AGA mice, which are good for testing baldness treatments, and both minoxidil and cyproterone acetate can prevent this hair loss.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.

CTA is often mistaken for AA but doesn't respond to steroids and may require hair transplantation.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.